Senate Appropriations Committee approves $164 billion funding bill
By
Lois A. Bowers
Jun 09, 2016
The Senate Appropriations Committee approved a $163.8 billion health and education funding bill Thursday that increases monies for medical research and the fight against opioid abuse, among other areas,...
More news for Friday, Aug. 30
Aug 30, 2019
1 year later: An update on the Welltower-ProMedica partnership … New York Times opinion piece says assisted living is “how not to grow old in America” … Drinking coffee may ease tremors in...
Estimate of annual cost of Parkinson’s doubles to $52 billion in new study
By
Lois A. Bowers
Jun 17, 2019
The total cost of Parkinson’s disease to individuals, families and the U.S. government is $51.9 billion every year, according to a new estimate released by the Michael J. Fox Foundation for Parkinson’s...
3 new dementia studies of note
Oct 27, 2015
New research quantifies costs associated with dementia care compared with other diseases and offers a little good news for those with Lewy body dementia or Alzheimer’s disease.
More news for Wednesday, March 8
Mar 07, 2017
AHCA/NCAL says Seema Verma ‘pragmatic leader we need at CMS’ … Alzheimer’s $259 billion cost could break Medicare … Head injuries can lead to Alzheimer’s, Parkinson’s...
Relapse risk for psychosis in dementia lower with continued pimavanserin
Jul 22, 2021
The findings were seen in a double-blind, randomized, placebo-controlled discontinuation trial that was stopped early for efficacy.
Parkinson’s drugs up risk of compulsive behavior: review
By
Lois A. Bowers
Apr 07, 2016
New research links dopamine agonists, commonly prescribed to help control tremors and other symptoms of Parkinson’s disease, with impulse control disorders.
Monoclonal antibodies no better than placebo for early Parkinson’s disease
Aug 04, 2022
Two studies show a lack of benefit in primary or secondary end points with cinpanemab or prasinezumab versus placebo.
‘First-ever’ legislation to end Parkinson’s disease introduced in House
By
Lois A. Bowers
Aug 01, 2022
A bipartisan bill that the Michael J. Fox Foundation for Parkinson’s Research is calling “the first-ever legislation solely devoted to ending Parkinson’s disease” has been introduced in the House...